Biotech · Private company
Ellodi Pharmaceuticals, LP
Track this companyFree. Adds Ellodi Pharmaceuticals, LP to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- APT-1011Phase 3 · Eosinophilic EsophagitisClinicalTrials.gov · fetched Nov 12, 2026
- EsophagogastroduodenoscopyPhase 3 · Eosinophilic EsophagitisClinicalTrials.gov · fetched Nov 12, 2026
- APT-1011 3 mg HSEosinophilic EsophagitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- 24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)PHASE3 · COMPLETED · started Dec 29, 2022ClinicalTrials.gov NCT05634746 · fetched Nov 12, 2026
- Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 TrialPHASE3 · COMPLETED · started Sep 30, 2021ClinicalTrials.gov NCT05083312 · fetched Nov 12, 2026
- Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)PHASE3 · COMPLETED · started Jan 30, 2020ClinicalTrials.gov NCT04281108 · fetched Nov 12, 2026
- Expanded Access Protocol for Patients With Eosinophilic EsophagitisNO_LONGER_AVAILABLEClinicalTrials.gov NCT05095116 · fetched Nov 12, 2026